Publication | Closed Access
Pregabalin Vs. Opioids for the Treatment of Neuropathic Cancer Pain: A Prospective, Head‐to‐Head, Randomized, Open‐Label Study
47
Citations
36
References
2013
Year
Prompt use of a neuropathic pain-specific adjuvant, such as pregabalin, in NCP may lead to better control of the neuropathic component, with opioid-sparing effects.
| Year | Citations | |
|---|---|---|
Page 1
Page 1